Literature DB >> 23245723

Recombinant activated factor VII as an additional agent in the management of bleeding in patients with chemotherapy-induced thrombocytopenia.

Pavol Hollý, Lenka Lisá, Ivana Plameňová, Miroslava Dobrotová, Peter Kubisz.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2012        PMID： 23245723      PMCID： PMC3729145          DOI： 10.2450/2012.0077-12

Source DB:  PubMed          Journal:  Blood Transfus        ISSN： 1723-2007            Impact factor:   3.443


× No keyword cloud information.
  5 in total

1.  Recombinant factor VIIa for the management of severe hemorrhages in patients with hematologic malignancies.

Authors:  Paolo De Fabritiis; Teresa Dentamaro; Alessandra Picardi; Laura Cudillo; Mario Masi; Sergio Amadori
Journal:  Haematologica       Date:  2004-02       Impact factor: 9.941

2.  Control of bleeding caused by thrombocytopenia associated with hematologic malignancy: an audit of the clinical use of recombinant activated factor VII.

Authors:  Benjamin Brenner; Ron Hoffman; Dmitriy Balashov; Elena Shutluko; Sr Dana Culić; Elena Nizamoutdinova
Journal:  Clin Appl Thromb Hemost       Date:  2005-10       Impact factor: 2.389

Review 3.  The use of recombinant activated factor VII in platelet disorders: a critical review of the literature.

Authors:  Massimo Franchini
Journal:  Blood Transfus       Date:  2009-01       Impact factor: 3.443

4.  Management of acquired bleeding problems in cancer patients.

Authors:  Thomas G DeLoughery
Journal:  Hematol Oncol Clin North Am       Date:  2010-06       Impact factor: 3.722

5.  Recombinant activated factor VII in treatment of bleeding complications following hematopoietic stem cell transplantation.

Authors:  M Pihusch; A Bacigalupo; J Szer; M von Depka Prondzinski; B Gaspar-Blaudschun; L Hyveled; B Brenner
Journal:  J Thromb Haemost       Date:  2005-09       Impact factor: 5.824
  5 in total
  1 in total

1.  Benefits of Thromboelastography and Thrombin Generation Assay for Bleeding Prediction in Patients With Thrombocytopenia or Hematologic Malignancies.

Authors:  Seon Young Kim; Ja Yoon Gu; Hyun Ju Yoo; Ji Eun Kim; Seonpyo Jang; Sooyeon Choe; Youngil Koh; Inho Kim; Hyun Kyung Kim
Journal:  Ann Lab Med       Date:  2017-11       Impact factor: 3.464
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.